<- Go Home
Allurion Technologies Inc.
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company operates in Spain, France, Turkey, and internationally. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.
Market Cap
$13.8M
Volume
803.2K
Cash and Equivalents
$6.1M
EBITDA
-$38.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$10.5M
Profit Margin
60.99%
52 Week High
$5.78
52 Week Low
$0.95
Dividend
N/A
Price / Book Value
-0.10
Price / Earnings
-0.19
Price / Tangible Book Value
-0.10
Enterprise Value
$90.9M
Enterprise Value / EBITDA
-2.43
Operating Income
-$39.6M
Return on Equity
44.06%
Return on Assets
-71.87
Cash and Short Term Investments
$6.1M
Debt
$83.3M
Equity
-$82.9M
Revenue
$17.2M
Unlevered FCF
-$19.9M
Sector
Diversified Consumer Services
Category
N/A